Interleukin-4 gene therapy - University of Pittsburgh
Alternative Names: S4-IL4Latest Information Update: 20 Nov 2007
At a glance
- Originator University of Pittsburgh
- Class Cytokine genes; Gene therapies; Interleukins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer pain
Most Recent Events
- 16 Jun 2003 Preclinical trials in Cancer pain in USA (unspecified route)